Teladoc Health, Inc.
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During the three months ended September 30, 2026, the following officer (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934)adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933):
On August 4, 2026, Carlos Nueno, our President, International, adopted a Rule 10b5-1 trading plan. Mr.Nueno’s trading plan provides for the sale of up to 224,564 shares of our common stock through December 2027.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.